PIRS Insider Trading

Insider Ownership Percentage: 7.30%
Insider Buying (Last 12 Months): $10,260.00
Insider Selling (Last 12 Months): $0.00

Pieris Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Pieris Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Pieris Pharmaceuticals Share Price & Price History

Current Price: $0.95
Price Change: +0.30 (1.20%)
As of 12/9/2022 01:00 AM ET

This chart shows the closing price history over time for PIRS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Pieris Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/13/2022Tim DemuthInsiderBuy6,000$1.71$10,260.006,000View SEC Filing Icon  
8/30/2021Shane OlwillInsiderSell38,400$5.11$196,224.00View SEC Filing Icon  
7/21/2020Aquilo Capital Management, LlcMajor ShareholderSell1,900,000$2.95$5,605,000.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Pieris Pharmaceuticals (NASDAQ:PIRS)

50.17% of Pieris Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PIRS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Pieris Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/22/2022B. Riley Wealth Advisors Inc.51,619$60K0.0%N/A0.069%Search for SEC Filing on Google Icon
11/15/2022Jacobs Levy Equity Management Inc.392,871$0.45M0.0%+155.3%0.528%Search for SEC Filing on Google Icon
11/15/2022Two Sigma Advisers LP90,700$0.10M0.0%-38.9%0.122%Search for SEC Filing on Google Icon
11/15/2022Two Sigma Investments LP37,759$43K0.0%N/A0.051%Search for SEC Filing on Google Icon
11/15/2022Platinum Investment Management Ltd.1,220,798$1.40M0.1%+11.1%1.641%Search for SEC Filing on Google Icon
11/15/2022Marshall Wace LLP2,441,195$2.81M0.0%-3.5%3.281%Search for SEC Filing on Google Icon
11/14/2022Annandale Capital LLC50,000$58K0.0%N/A0.067%Search for SEC Filing on Google Icon
11/14/2022Lynx1 Capital Management LP3,515,140$4.04M3.6%+9.1%4.724%Search for SEC Filing on Google Icon
11/14/2022Renaissance Technologies LLC731,100$0.84M0.0%+26.0%0.983%Search for SEC Filing on Google Icon
11/10/2022Connor Clark & Lunn Investment Management Ltd.133,662$0.15M0.0%+51.0%0.180%Search for SEC Filing on Google Icon
11/10/2022Dimensional Fund Advisors LP106,662$0.12M0.0%-24.6%0.143%Search for SEC Filing on Google Icon
11/10/2022Tower Research Capital LLC TRC 21,581$25K0.0%+9,665.2%0.029%Search for SEC Filing on Google Icon
8/18/2022Goldman Sachs Group Inc.79,532$0.15M0.0%-59.2%0.107%Search for SEC Filing on Google Icon
8/15/2022Cubist Systematic Strategies LLC17,470$33K0.0%-91.1%0.023%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC269,074$0.50M0.0%-62.2%0.362%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC580,091$1.09M0.0%+54.9%0.780%Search for SEC Filing on Google Icon
8/12/2022Rafferty Asset Management LLC29,622$55K0.0%+32.3%0.040%Search for SEC Filing on Google Icon
8/12/2022Franklin Resources Inc.29,863$56K0.0%-32.6%0.040%Search for SEC Filing on Google Icon
8/11/2022Sigma Planning Corp315,384$0.59M0.0%-12.6%0.424%Search for SEC Filing on Google Icon
8/11/2022Bank of Montreal Can789,500$2.60M0.0%N/A1.061%Search for SEC Filing on Google Icon
8/11/2022Platinum Investment Management Ltd.1,098,888$2.06M0.1%+6.9%1.477%Search for SEC Filing on Google Icon
8/10/2022Mackenzie Financial Corp13,649$26K0.0%N/A0.018%Search for SEC Filing on Google Icon
8/5/2022Connor Clark & Lunn Investment Management Ltd.88,502$0.17M0.0%-41.2%0.119%Search for SEC Filing on Google Icon
7/28/2022Cutter & CO Brokerage Inc.412,229$0.77M0.3%+1.5%0.556%Search for SEC Filing on Google Icon
6/7/2022Bank of America Corp DE573,839$1.74M0.0%+34.4%0.774%Search for SEC Filing on Google Icon
5/18/2022BNP Paribas Arbitrage SA32,383$98K0.0%-87.1%0.044%Search for SEC Filing on Google Icon
5/17/2022Mirabella Financial Services LLP12,800$39K0.0%N/A0.017%Search for SEC Filing on Google Icon
5/17/2022Jane Street Group LLC98,041$0.30M0.0%+42.1%0.132%Search for SEC Filing on Google Icon
5/17/2022Great Point Partners LLC2,199,076$6.66M1.6%+41.9%2.968%Search for SEC Filing on Google Icon
5/16/2022Goldman Sachs Group Inc.195,010$0.59M0.0%-59.6%0.263%Search for SEC Filing on Google Icon
5/16/2022Woodline Partners LP1,587,475$4.81M0.1%-35.6%2.142%Search for SEC Filing on Google Icon
5/16/2022State Street Corp213,499$0.65M0.0%+12.7%0.288%Search for SEC Filing on Google Icon
5/16/2022UBS Group AG21,954$67K0.0%N/A0.030%Search for SEC Filing on Google Icon
5/16/2022Hsbc Holdings PLC20,556$63K0.0%+55.6%0.028%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC374,591$1.14M0.0%+7.8%0.506%Search for SEC Filing on Google Icon
5/13/2022XTX Topco Ltd15,067$46K0.0%N/A0.020%Search for SEC Filing on Google Icon
5/13/2022Blair William & Co. IL128,745$0.39M0.0%+9.1%0.174%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.1,338,437$4.06M0.0%+1.6%1.806%Search for SEC Filing on Google Icon
5/12/2022Healthcare of Ontario Pension Plan Trust Fund416,800$1.26M0.0%N/A0.562%Search for SEC Filing on Google Icon
5/12/2022Citigroup Inc.477,960$1.45M0.0%-3.0%0.645%Search for SEC Filing on Google Icon
5/12/2022Connor Clark & Lunn Investment Management Ltd.150,492$0.46M0.0%-42.0%0.203%Search for SEC Filing on Google Icon
5/12/2022Oppenheimer & Co. Inc.10,500$32K0.0%N/A0.014%Search for SEC Filing on Google Icon
5/11/2022JPMorgan Chase & Co.63,643$0.19M0.0%+149.9%0.086%Search for SEC Filing on Google Icon
5/9/2022Commerce Bank20,000$61K0.0%N/A0.027%Search for SEC Filing on Google Icon
5/3/2022Cutter & CO Brokerage Inc.406,229$1.23M0.4%+2.9%0.548%Search for SEC Filing on Google Icon
4/25/2022Bailard Inc.19,600$59K0.0%N/A0.026%Search for SEC Filing on Google Icon
4/25/2022Assenagon Asset Management S.A.1,208,226$3.66M0.0%-18.1%1.631%Search for SEC Filing on Google Icon
2/19/2022Woodline Partners LP2,463,641$9.31M0.1%N/A3.419%Search for SEC Filing on Google Icon
2/15/2022Lynx1 Capital Management LP383,266$1.45M1.3%N/A0.532%Search for SEC Filing on Google Icon
2/14/2022Soleus Capital Management L.P.687,412$2.60M0.3%-7.1%0.954%Search for SEC Filing on Google Icon
2/14/2022Blair William & Co. IL117,985$0.45M0.0%+686.6%0.164%Search for SEC Filing on Google Icon
2/10/2022Qube Research & Technologies Ltd24,883$94K0.0%N/A0.035%Search for SEC Filing on Google Icon
2/10/2022Cutter & CO Brokerage Inc.394,800$1.49M0.4%+21.1%0.548%Search for SEC Filing on Google Icon
2/10/2022Rafferty Asset Management LLC20,547$78K0.0%-35.4%0.029%Search for SEC Filing on Google Icon
2/10/2022Citigroup Inc.492,494$1.86M0.0%+3.9%0.683%Search for SEC Filing on Google Icon
2/10/2022Acadian Asset Management LLC347,243$1.31M0.0%+380.0%0.482%Search for SEC Filing on Google Icon
2/10/2022OLD Mission Capital LLC70,092$0.27M0.0%N/A0.097%Search for SEC Filing on Google Icon
2/10/2022Connor Clark & Lunn Investment Management Ltd.259,670$0.98M0.0%+4.6%0.360%Search for SEC Filing on Google Icon
2/9/2022BNP Paribas Arbitrage SA250,219$0.95M0.0%+29,546.8%0.347%Search for SEC Filing on Google Icon
2/9/2022Wealth Effects LLC87,300$0.33M0.1%N/A0.121%Search for SEC Filing on Google Icon
2/7/2022SG Americas Securities LLC18,400$70K0.0%N/A0.026%Search for SEC Filing on Google Icon
2/2/2022Sigma Planning Corp359,234$1.36M0.0%-1.4%0.499%Search for SEC Filing on Google Icon
2/1/2022Assenagon Asset Management S.A.1,475,778$5.58M0.0%+358.0%2.048%Search for SEC Filing on Google Icon
2/1/2022Qube Research & Technologies Ltd24,883$94K0.0%N/A0.035%Search for SEC Filing on Google Icon
11/16/2021Cetera Advisors LLC10,100$52K0.0%N/A0.014%Search for SEC Filing on Google Icon
11/16/2021Squarepoint Ops LLC35,592$0.18M0.0%-72.5%0.049%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Advisers LP1,114,700$5.76M0.0%N/A1.547%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Investments LP1,167,548$6.04M0.0%N/A1.620%Search for SEC Filing on Google Icon
11/16/2021Millennium Management LLC2,046,850$10.58M0.0%-30.7%2.840%Search for SEC Filing on Google Icon
11/15/2021Cubist Systematic Strategies LLC432,289$2.24M0.0%+913.7%0.600%Search for SEC Filing on Google Icon
11/15/2021Marshall Wace LLP219,428$1.13M0.0%+975.2%0.304%Search for SEC Filing on Google Icon
11/15/2021Invesco Ltd.1,501,699$7.76M0.0%N/A2.084%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC300,851$1.56M0.0%-62.9%0.417%Search for SEC Filing on Google Icon
11/12/2021Jump Financial LLC87,831$0.45M0.0%N/A0.122%Search for SEC Filing on Google Icon
11/12/2021Hsbc Holdings PLC13,213$70K0.0%N/A0.018%Search for SEC Filing on Google Icon
11/12/2021Credit Suisse AG68,940$0.36M0.0%-10.1%0.096%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC693,696$3.59M0.0%+21.2%0.963%Search for SEC Filing on Google Icon
11/12/2021B. Riley Wealth Management Inc.33,000$0.17M0.0%N/A0.046%Search for SEC Filing on Google Icon
11/12/2021Connor Clark & Lunn Investment Management Ltd.248,308$1.28M0.0%N/A0.345%Search for SEC Filing on Google Icon
11/10/2021Goldman Sachs Group Inc.498,581$2.58M0.0%+2,240.3%0.692%Search for SEC Filing on Google Icon
11/10/2021Citigroup Inc.473,816$2.45M0.0%+14.6%0.658%Search for SEC Filing on Google Icon
11/10/2021Rafferty Asset Management LLC31,796$0.16M0.0%N/A0.044%Search for SEC Filing on Google Icon
11/9/2021Barclays PLC40,339$0.21M0.0%+523.0%0.056%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.1,276,990$6.60M0.0%-2.0%1.772%Search for SEC Filing on Google Icon
11/9/2021Platinum Investment Management Ltd.1,028,322$5.32M0.1%-11.7%1.427%Search for SEC Filing on Google Icon
11/2/2021Cutter & CO Brokerage Inc.326,100$1.69M0.4%N/A0.489%Search for SEC Filing on Google Icon
10/28/2021Sigma Planning Corp364,484$1.88M0.1%+1.3%0.546%Search for SEC Filing on Google Icon
10/28/2021Truepoint Inc.10,000$52K0.0%N/A0.015%Search for SEC Filing on Google Icon
10/19/2021Assenagon Asset Management S.A.322,241$1.67M0.0%+8.0%0.483%Search for SEC Filing on Google Icon
8/26/2021Y Intercept Hong Kong Ltd10,867$42K0.0%N/A0.016%Search for SEC Filing on Google Icon
8/25/2021Marshall Wace LLP20,409$78K0.0%N/A0.031%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC2,952,631$11.31M0.0%N/A4.426%Search for SEC Filing on Google Icon
8/17/2021BVF Inc. IL5,328,239$20.41M0.8%-3.0%7.987%Search for SEC Filing on Google Icon
8/16/2021Squarepoint Ops LLC129,608$0.50M0.0%N/A0.194%Search for SEC Filing on Google Icon
8/16/2021LMR Partners LLP23,158$89K0.0%N/A0.035%Search for SEC Filing on Google Icon
8/16/2021Point72 Asset Management L.P.1,000,000$3.83M0.0%N/A1.499%Search for SEC Filing on Google Icon
8/16/2021Cubist Systematic Strategies LLC42,643$0.16M0.0%N/A0.064%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley1,675,969$6.42M0.0%+104.6%2.512%Search for SEC Filing on Google Icon
8/16/2021Credit Suisse AG76,683$0.29M0.0%-5.9%0.115%Search for SEC Filing on Google Icon
8/16/2021Schonfeld Strategic Advisors LLC10,980$42K0.0%N/A0.016%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Pieris Pharmaceuticals logo
Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs. The company develops anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins found in human blood plasma and other bodily fluids. Its lead respiratory Anticalin-based drug candidate includes PRS-060/AZD1402, a drug candidate that is in Phase II clinical trial targeting IL-4Ra for the treatment of asthma and other inflammatory diseases; PRS-220, an oral inhaled Anticalin protein targeting connective tissue growth factor for the treatment of idiopathic pulmonary fibrosis; and immune-oncology program comprises Cinrebafusp alfa, a 4-1BB/ HER2 bispecific for the treatment of HER2-high and HER2-low expressing gastric cancers. The company also develops PRS-344/S095012, a bispecific anticalin-antibody fusion protein targeting 4- 1BB and PD-L1 for immuno-oncology diseases that is in phase 1 clinical trial; and PRS-352, a preclinical-stage program addressing undisclosed targets for immuno-oncology diseases. It has a license and collaboration agreement with Les Laboratoires Servier and Institut de Recherches Internationales Servier, AstraZeneca AB, and Seagen Inc.; and license agreements with Technical University of Munich, Enumeral Biomedical Holdings, Inc., and Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. The company also has a clinical trial collaboration and supply agreement with Eli Lilly and Company. Pieris Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Boston, Massachusetts.
Read More on Pieris Pharmaceuticals

Today's Range

Now: $0.95
Low: $0.94
High: $1.00

50 Day Range

MA: $1.02
Low: $0.94
High: $1.19

52 Week Range

Now: $0.95
Low: $0.92
High: $4.08

Volume

242,403 shs

Average Volume

369,697 shs

Market Capitalization

$70.56 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.01

Who are the company insiders with the largest holdings of Pieris Pharmaceuticals?

Pieris Pharmaceuticals' top insider investors include:
  1. Tim Demuth (Insider)
  2. Shane Olwill (Insider)
Learn More about top insider investors at Pieris Pharmaceuticals.

Who are the major institutional investors of Pieris Pharmaceuticals?

Pieris Pharmaceuticals' top institutional investors include:
  1. Lynx1 Capital Management LP — 4.72%
  2. Marshall Wace LLP — 3.28%
  3. Platinum Investment Management Ltd. — 1.64%
  4. Renaissance Technologies LLC — 0.98%
  5. Jacobs Levy Equity Management Inc. — 0.53%
  6. Connor Clark & Lunn Investment Management Ltd. — 0.18%
Learn More about top institutional investors of Pieris Pharmaceuticals stock.

Which institutional investors are selling Pieris Pharmaceuticals stock?

In the previous quarter, PIRS stock was sold by these institutional investors:
  1. Marshall Wace LLP
  2. Two Sigma Advisers LP
  3. Dimensional Fund Advisors LP

Which institutional investors are buying Pieris Pharmaceuticals stock?

In the previous quarter, PIRS stock was acquired by institutional investors including:
  1. Lynx1 Capital Management LP
  2. Jacobs Levy Equity Management Inc.
  3. Renaissance Technologies LLC
  4. Platinum Investment Management Ltd.
  5. B. Riley Wealth Advisors Inc.
  6. Annandale Capital LLC
  7. Connor Clark & Lunn Investment Management Ltd.
  8. Two Sigma Investments LP